[A case of advanced rectal cancer responding to 5-fluorouracil based preoperative chemoradiation therapy]. 2005

Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
Dept. of Digestive and Pediatric Surgery, Graduate School of Medicine, The University of Tokushima.

We report a case of a 67-year-old female with advanced rectal cancer that showed a significant response after administration of preoperative chemoradiation therapy. 5-fluorouracil (5-FU, 300 mg/m2/day) was administered by 24-hour continuous intravenous infusion after the cancer had been decreased in size by radiation (2 Gy) administered for 20 days preoperatively. Consequently, the patient underwent a low anterior resection with lymph node dissection (D 2), which resulted in a curative resection of the cancer cells macroscopically. Histological examination revealed no residual cancer cells in the resected specimen (CR). Preoperative chemoradiation therapy appears a promising regimen for patients with advanced lower rectal cancer, and can be considered to extend the indication for laparoscopic operations for advanced rectal cancer.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
October 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
February 2013, Anticancer research,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
November 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
January 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
January 2014, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
January 2008, Hematology/oncology and stem cell therapy,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
November 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
November 2011, International journal of radiation oncology, biology, physics,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
January 2001, Japanese journal of clinical oncology,
Tetsuya Ikemoto, and Masaki Nishioka, and Tsutomu Ando, and Yuko Yawata, and Yoshiyasu Terashima, and Hitoshi Ikushima, and Mitsuo Shimada
May 1998, Cancer control : journal of the Moffitt Cancer Center,
Copied contents to your clipboard!